Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a Blood Advances 2025 Dec 9 publication citation for Camidanlumab tesirine phase 2 study and removed the earlier Blood Advances online-ahead-of-print citation.
    Difference
    0.0%
    Check dated 2025-12-26T14:16:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Locations were expanded to include a comprehensive list of study sites (Arizona, California, Florida, Georgia, Illinois, Kentucky, Minnesota, Missouri, New Jersey, New York, Ohio, South Carolina, Texas, Virginia, Wisconsin, and British Columbia) and the study revision was updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-19T10:29:15.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces the previous v3.3.1 label on the page header/footer. This is a minor metadata update and does not affect the study details or navigation.
    Difference
    0.0%
    Check dated 2025-11-28T02:39:53.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Publications notes now clarify that the list is auto-populated from PubMed, and reflect Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-20T22:39:12.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Notice regarding government funding status and NIH operation updates has been removed from the page. This change does not alter the study details, eligibility, outcomes, or how users interact with the page.
    Difference
    0.2%
    Check dated 2025-11-13T16:59:47.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    No significant changes detected; the page content, study details, eligibility criteria, and locations remain the same.
    Difference
    0.3%
    Check dated 2025-10-30T11:20:10.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.